GLYCOMIMETICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.83 USD | +6.40% |
|
+11.59% | -22.46% |
| 27/03 | Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024 | |
| 27/03 | GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar GlycoMimetics, Inc.
ee9e38064edbd063aedd7fb8d3acdcf.PiQt3IjKSUEIrTxocuJU057VIyR_5BHqtt_s4cdVG88.cWtC5OH6CCVQ134dEJMaudnsckkwjVO-wI-lhJMkevlZZxySsfwoL27GZQ~b5101b2279b3d68a3bf4303fe7c2f7bc
Upcoming events on GlycoMimetics, Inc.
Past events on GlycoMimetics, Inc.
| 01/05/2024 06:30 pm | Annual General Meeting |
| 27/03/2024 06:00 pm | Q4 2023 Earnings Call |
| 27/03/2024 04:30 pm | Q4 2023 Earnings Release |
| 04/03/2024 11:20 pm | TD Cowen Health Care Conference |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - Poster No: 2922 |
| 10/12/2023 07:00 am | American Society of Hematology Meeting - Poster No: 1492 |
| 16/11/2023 07:00 pm | Jefferies London Healthcare Conference |
| 03/11/2023 06:00 pm | Q3 2023 Earnings Call |
| 03/11/2023 04:30 pm | Q3 2023 Earnings Release |
| 13/09/2023 09:00 pm | H.C. Wainwright Global Investment Conference |
| 02/08/2023 06:00 pm | Q2 2023 Earnings Call |
| 02/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 08/06/2023 01:30 am | Jefferies Global Healthcare Conference - Fireside Chat |
| 19/05/2023 06:30 pm | Annual General Meeting |
| 03/05/2023 06:00 pm | Q1 2023 Earnings Call |
| 03/05/2023 04:30 pm | Q1 2023 Earnings Release |
| 29/03/2023 06:00 pm | Q4 2022 Earnings Call |
| 29/03/2023 04:30 pm | Q4 2022 Earnings Release |
| 08/03/2023 11:20 pm | Cowen Health Care Conference - Panel |
| 12/12/2022 | American Society of Hematology Meeting - Publication Number: 2764 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 10,2 8,40 20.99% | 1,16 1,13 2.84% | 0,08 0,05 50% | 0,01 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -61,4 -61,8 0.7% | -51,5 -51,7 0.44% | -63,4 -63,9 0.68% | -47,4 -45,7 -3.66% | -39,3 -39,8 1.23% | -41,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -57,9 -57,2 -1.23% | -51,0 -50,7 -0.72% | -63,4 -62,2 -1.97% | -46,7 -45,9 -1.72% | -36,9 -37,4 1.34% | -41,2 |
|
Net income Million USD | Released Forecast Spread | -57,9 -57,3 -0.97% | -51,0 -50,9 -0.25% | -63,4 -63,6 0.32% | -46,7 -45,4 -2.75% | -36,9 -37,5 1.7% | -40,6 |
|
EPS USD | Released Forecast Spread | -1,34 -1,31 -2.16% | -1,12 -1,11 -0.54% | -1,23 -1,25 1.4% | -0,89 -0,87 -2.3% | -0,58 -0,60 3.73% | -0,59 |
| Announcement Date | 28/02/20 | 02/03/21 | 03/03/22 | 29/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,02 0,00 - | 0,00 0,00 - | 0,08 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,03 - | 0,00 0,00 - | 0,01 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -17,4 -17,9 2.75% | -14,7 -16,2 9.44% | -13,4 -14,8 9.69% | -8,77 -14,2 38.38% | -10,6 -8,91 -19.23% | -10,9 -10,4 -5.51% | -8,93 -11,2 20.52% | -9,81 -9,27 -5.88% | -9,59 -10,1 4.79% | -9,88 | -10,1 | -10,3 | -10,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,4 -16,3 -6.88% | -14,7 -15,6 5.77% | -13,3 -15,1 12.14% | -8,52 -15,7 45.71% | -10,2 -9,00 -13.83% | -10,4 -11,0 5.83% | -8,26 -13,4 38.37% | -9,20 -9,40 2.1% | -9,08 -9,59 5.33% | ||||
|
Net income Million USD | Released Forecast Spread | -17,4 -17,7 1.46% | -14,7 -16,0 8.35% | -13,3 -14,8 10.25% | -8,52 -14,2 40% | -10,2 -8,84 -15.89% | -10,4 -10,3 -1.04% | -8,26 -11,6 29.04% | -9,20 -9,07 -1.48% | -9,08 -9,72 6.61% | -9,66 | -9,89 | -10,2 | -10,6 |
|
EPS USD | Released Forecast Spread | -0,33 -0,34 3.65% | -0,28 -0,31 8.7% | -0,25 -0,29 12.28% | -0,16 -0,26 39.24% | -0,19 -0,17 -14% | -0,17 -0,17 -2% | -0,13 -0,18 29.09% | -0,14 -0,14 2.32% | -0,14 -0,15 8.2% | -0,15 | -0,15 | -0,14 | -0,15 |
| Announcement Date | 03/03/22 | 28/04/22 | 03/08/22 | 09/11/22 | 29/03/23 | 03/05/23 | 02/08/23 | 03/11/23 | 27/03/24 | - | - | - | - |
More events
Past sector events for GlycoMimetics, Inc.
| 03/05/2024 01:35 am | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:32 am | ARDELYX, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 03/05/2024 01:30 am | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GLYC Stock
- Calendar GlycoMimetics, Inc.
